Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dermafiller is a global distributor and supplier specializing in aesthetic medicine and medical devices, primarily focusing on dermal fillers and skin rejuvenation products. The company provides a wide range of hyaluronic acid-based injectables, botulinum toxins, and mesotherapy solutions to healthcare professionals and clinics worldwide. Their portfolio includes well-known brands such as Juvederm, Restylane, and Teosyal, alongside their own specialized offerings. Dermafiller operates as a key link in the aesthetic supply chain, ensuring the availability of high-quality cosmetic treatments for facial contouring and anti-aging procedures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dermafiller.